Antileprosy vaccinations;Vacinação anti-hansênica

Anais Brasileiros de Dermatologia

Volumn 77, Issue 4, 2002, Pages 489-494

  Azulay, Rubem David ^a  

^a NONE   (Brazil)

Author keywords

BCG Vaccine; Leprosy

Indexed keywords

BCG VACCINE; LEPROSY VACCINE;

HUMAN; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; LEPROSY; LEPROSY CONTROL; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM LEPRAE; REVIEW; SPECIES; VACCINATION;

EID: 0036631005     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Précis de Leprologia
2. Estudio comparativo de la reacción de Mitsuda com las reacciones tuberculinicas
3. La reacción de Mitsuda en los vacinados com BCG: Possibilidad de la vacinación BCG en la profilaxis de la lepra
4. Ação do BCG sobre a reação lepromínica
5. The protective role of BCG in murine Leprosy
6. Vaccination against experimental infection with Mycobacterium leprae
7. Towards development of a vaccine against leprosy
8. Five cultivable Mycobacterial strains giving blast transformation and leucocyte migration inhibition of leucocytes analogous to Mycobacterium leprae
9. Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients
10. Combined multidrug and Mycobacterium w vaccine therapy in patient with multibacillary leprosy
11. Field trials on the use of Mycobacterium w vaccine in conjunction with multidrug therapy in leprosy patients for immunotherapeutic and immunoprophylactic purposes
12. Potential antileprosy vaccine from killed ICRC bacilli: A clinicopathological study
13. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: Preliminary results
14. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis
15. Immunotherapy of Lepromine - Negative Borderline Leprosy patients with low-dose Convit Vaccine as an adjunct to multidrug therapy: A six-year follow-up study in Calcutta
16. Protektivnye svo istva M. lufu prieksperimental'no i leprozno i infektsil
17. Lymphostimulatory and delayed-type hypersensitivity responses to a candidate leprosy vaccine strain: Mycobacterium habana
18. Primary prevention of Leprosy
19. Incidence rates of Leprosy in Karonga District, Northern Malawi: Patterns by age, sex, BCG status and classification
20. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya
21. The case for BCG
22. Protective efficacy of BCG against leprosy in São Paulo
23. Randomized controlled trial of single BCG, repeated BCG or combined BCG and killed M. leprae vaccine for prevention of leprosy and tuberculosis in Malawi
24. Does bacille Calmette-Guerin scar size have implication for protection against tuberculosis or leprosy?
25. BCG vaccination protects against Leprosy in Venezuela: A case-control study
26. Antileprosy vaccine: An apprehension
27. Leprosy and BCG in southern Vietnam
28. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with Calmette-Guerin from infection with Mycobacterium tuberculosis
29. A viragem da reação leprominica pelo BCG administrado aos doentes lepromatosos em condições clinico-bacterioscópico-histopatológicos de "Transferência para Dispensário"
30. Protective effect of intradermal BCG against Leprosy: A case-control study in central Brazil
31. Protective efficacy of BCG vaccine against leprosy in southern Malawi
32. Protective efficacy of BCG against leprosy in northern Malawi
33. Effect of BCG on the risk of Leprosy in an endemic area: A case-control study
34. BCG vaccination of children against leprosy: Preliminary findings of the WHO-controlled trial in Burma
35. Delayed-type Hypersensitivity, mycobacterial vaccines and protective immunity
36. Prophylaxis-scope and limitations. Workshop Proceedings
37. Antileprosy protective vaccination of Rhesus monkeys with BCG or BCG plus heat-killed M. leprae: Immunologic observations